DCC Nursing Education Series: Vesicant Chemotherapy – Preventing and Managing Extravasations

Friday, February 23, 2024, 12:00 PM - Tuesday, February 23, 2027, 1:00 PM

ANCC Nursing Contact Hours (1.00 hours), General Attendance (1.00 hours)

This activity presents an overview of preventing and managing extravasations in patients receiving vesicant chemotherapy agents. Topics include: differences between vesicant and irritant chemotherapy; how to differentiate between an extravasation, infiltration, and flare reaction; etiology and risk factors for development of extravasations in both peripheral intravenous catheters and central venous access devices; factors affecting the severity of tissue damage in the event of an extravasation; signs and symptoms of vesicant extravasation; and current guidelines and best practices regarding preventing and managing vesicant extravasations.

1. Describe the role and responsibilities of the nurse in preventing and managing extravasations when administering vesicant chemotherapy agents.

In support of improving patient care, Dartmouth Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

American Nurses Credentialing Center (ANCC)
Dartmouth Health designates this Enduring Material for a maximum of 1.00 ANCC contact hours.

All other learners may claim General participation credit. Consult your professional licensing board regarding the applicability and acceptance of general attendance credit for programs certified for credit by organizations accredited by Joint Accreditation for Interprofessional Education.

Registration/Requirements for Successful Completion
You may claim credit for successful completion of this online course. In order to claim credit, you must follow these steps:

1. Click the Register tab above. If you are not logged into your account, you will need to log in. Use the Forgot Your Password? button if you need to reset your password.
2. Register for the activity.
3. Click the Content/Tests tab and then View Content to view the recording. View the entire presentation.
4. Complete the Post-Test (attestation - return to the Content/Tests tab to find it).
5. Click the Complete Evaluation button, or click My Account in the menu bar; then click Evaluations.
6. Complete and Submit the Evaluation.

Bibliographic Sources

• Buter, J., Steele, K. T., Chung, K. C., & Elzinga, K. (2023). Extravasation injury from cytotoxic and other noncytotoxic vesicants in adults. UpToDate. Retrieved December 22, 2023 from https://www.uptodate.com
  
  
• Ehmke, N. J. (2021). Chemotherapy extravasation: Incidence of and factors associated with events in a community cancer center. Clinical Journal of Oncology Nursing, 25(6), 680-686. Chemotherapy Extravasation: Incidence of and Factors Associated With Events in a Community Cancer Center | ONS   
  
  
• Gill, J. M., Frost, J., Park, R., & Saria, M. G. (2018). Venous flare reactions: A case report of reactions following etoposide infusion. Clinical Journal of Oncology Nursing, 22(6), 597-599. Venous Flare Reactions: A Case Report of Reactions Following Etoposide Infusion | ONS
  
  
• Jackson-Rose, J., Del Monte, J., Groman, A., Dial, L. S., Atwell, L., Graham, J., Semler, R. O., O’Sullivan, M., Truini-Pittman, L., Cunningham, T. A., Roman-Fischetti, L., Costantinou, E., Rimkus, C., Banavage, A. J., Dietz, B., Colussi, C. J., Catania, K., Wasko, M., Schreffler, K. A.,…Rice, R. D. (2017). Chemotherapy extravasation: Establishing a national benchmark for incidence among cancer centers. Clinical Journal of Oncology Nursing, 21(4), 438-445. Chemotherapy Extravasation: Establishing a National Benchmark for Incidence Among Cancer Centers | ONS 
  
  
• Oncology Nursing Society. (2019). Infusion-related complications. In M. M. Olsen, K. B. LeFebvre & K. J. Brassil (Eds.), Chemotherapy and Immunotherapy Guidelines and Recommendations for Practice (1st ed., pp. 251-270). Oncology Nursing Society. 
  
  
• Warner, J. (2023, April 26). Vesicant & irritant chemotherapy. HemOnc.org. Retrieved December 22, 2023 from Vesicant & irritant chemotherapy | HemOnc.org - A Hematology Oncology Wiki
  
  

Provider Contact Information
Provider contact information for questions regarding accreditation of the activity:

Center for Learning and Professional Development
CE Office
Dartmouth Health
[email protected]

Mitigation of Relevant Financial Relationships

Dartmouth Health adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education.  Any individuals in a position to control the content of a CE activity, including planners, faculty, authors, or others are required to disclose all financial relationships with ineligible companies^.  All relevant financial relationships have been mitigated prior to the commencement of the activity.

^Ineligible Company is any entity whose primary business purpose is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.